Log in
Enquire now
‌

US Patent 11020466 BCMA chimeric antigen receptors

Patent 11020466 was granted and assigned to Bluebird Bio on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Bluebird Bio
Bluebird Bio
Date Filed
October 23, 2020
Date of Patent
June 1, 2021
Patent Applicant
Bluebird Bio
Bluebird Bio
Patent Application Number
17079072
Patent Citations
‌
US Patent 10639359 BCMA chimeric antigen receptors
‌
US Patent 10639358 BCMA chimeric antigen receptors
‌
US Patent 10646558 BCMA chimeric antigen receptors
‌
US Patent 10774343 MND promoter chimeric antigen receptors
‌
US Patent 10383929 BCMA chimeric antigen receptors
‌
US Patent 10479975 Methods of making T cell compositions
‌
US Patent 10624960 BCMA chimeric antigen receptors
Patent Citations Received
‌
US Patent 12109234 Anti-BCMA CAR T cell compositions
0
‌
US Patent 11560547 Methods of making T cell compositions
‌
US Patent 11976084 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 12006369 BCMA chimeric antigen receptors
0
‌
US Patent 11479755 T cell compositions
‌
US Patent 11633463 BCMA chimeric antigen receptors
0
‌
US Patent 11319325 Macrocyclic spiropyrrolidine derived antiviral agents
‌
US Patent 11325916 Spiropyrrolidine derived antiviral agents
‌
US Patent 11339170 Spiropyrrolidine derived antiviral agents
‌
US Patent 11351236 BCMA chimeric antigen receptors
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11020466
Patent Primary Examiner
‌
James D Schultz

Find more entities like US Patent 11020466 BCMA chimeric antigen receptors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.